1977
DOI: 10.1021/bi00636a032
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition of Newcastle disease virion messenger RNA (guanine-7-)-methyltransferase by analogs of S-adenosylhomocysteine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
33
0

Year Published

1980
1980
2016
2016

Publication Types

Select...
3
3
1

Relationship

0
7

Authors

Journals

citations
Cited by 72 publications
(33 citation statements)
references
References 23 publications
0
33
0
Order By: Relevance
“…Although STH does inhibit the (guanine-7)-methyltransferases of Newcastle disease virus and vaccinia virus in vitro (24,25), it apparently did not inhibit m7G formation in Novikoff cells (19).…”
mentioning
confidence: 94%
“…Although STH does inhibit the (guanine-7)-methyltransferases of Newcastle disease virus and vaccinia virus in vitro (24,25), it apparently did not inhibit m7G formation in Novikoff cells (19).…”
mentioning
confidence: 94%
“…Lymphocytotoxicity of this compound could be mediated in part through this mechanism. Secondly, inhibition of transmethylation reactions could have significance as a mechanism of antiviral action for ara-A, especially because inhibition of transmethylation reactions has established antiviral properties (8)(9)(10)(11)(12). Whereas no specific data is presented here to implicate this pathway as the antiviral mechanism, the in vivo potential for transmethylation inhibition is provided by Ado-Hcy inactivation.…”
Section: Methodsmentioning
confidence: 99%
“…Because other methylation inhibitors possess antiviral activity (8)(9)(10)(11)(12), and methylation reactions are widely distributed in intermediary metabolism (13), it is possible that this property could contribute to the antiviral action and systemic toxicity of ara-A. To clarify whether Ado-Hcy hydrolase inactivation occurs during ara-A therapy, and the kinetics of this reaction in vivo, we have examined the alterations of Ado-Hcy hydrolase during low-dose therapy of chronic hepatitis B virus infection.…”
Section: Introductionmentioning
confidence: 99%
“…[53][54][55][56] The development of PNMT inhibitors and protein carboxyl methyltransferase arose from fruitful collaborations with fellow KU faculty members Professors Gary Grunewald and Charles O. Rutledge, respectively.…”
Section: Transmethylation and S-adenosyl-l-homocysteine Hydrolasementioning
confidence: 99%